Association between serum ALT levels and incidence of new-onset diabetes in general population of Japanese: a longitudinal observational study (ISSA-CKD).


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
07 08 2023
Historique:
medline: 9 8 2023
pubmed: 8 8 2023
entrez: 7 8 2023
Statut: epublish

Résumé

We aimed to clarify the relationship between serum alanine transaminase (ALT) levels and incidence of new-onset diabetes in a Japanese general population. Population-based retrospective cohort study using annual health check-up data for residents of Iki City, Nagasaki Prefecture, Japan. A total of 5330 Japanese individuals (≥30 years old) without diabetes at baseline were analysed. Serum ALT levels were determined using an enzymatic method and were classified into gender-specific quartile groups as follows: group 1 (3-16 U/L in men and 3-13 U/L in women), group 2 (17-21 U/L in men and 14-16 U/L in women), group 3 (22-29 U/L in men and 17-22 U/L in women) and group 4 (30-428 U/L in men and 23-268 U/L in women). The study outcome was the incidence of diabetes (fasting glucose ≥7.0 mmol/L, non-fasting glucose ≥11.1 mmol/L, glycated haemoglobin ≥6.5% or use of glucose-lowering therapies). After an average follow-up period of 5.0 years, 279 individuals developed diabetes. The incidence rate of diabetes increased with elevation of serum ALT levels (0.7% per 100 person-years in group 1, 0.9% in group 2, 0.9% in group 3 and 1.7% in group 4) (p<0.001 for trend). This association was significant after adjustment for other risk factors including age, sex, obesity, hypertension, dyslipidaemia, smoking, current daily alcohol intake and regular exercise (p<0.001 for trend). Comparable associations were observed between men and women (p=0.459 for interaction). Serum ALT levels were associated with future development of diabetes in the general Japanese population.

Identifiants

pubmed: 37550028
pii: bmjopen-2023-074007
doi: 10.1136/bmjopen-2023-074007
pmc: PMC10407361
doi:

Substances chimiques

Alanine Transaminase EC 2.6.1.2
Glucose IY9XDZ35W2

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e074007

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Diabetes Care. 2011 Dec;34(12):2603-7
pubmed: 21953798
J Epidemiol. 2017 Dec;27(12):553-561
pubmed: 28716381
Diabetologia. 2016 Dec;59(12):2527-2545
pubmed: 27747395
J Virol. 2008 Mar;82(6):2606-12
pubmed: 18160431
Diabetol Metab Syndr. 2014 Feb 06;6(1):14
pubmed: 24502834
J Clin Med. 2021 May 01;10(9):
pubmed: 34062802
J Hum Hypertens. 2019 Dec;33(12):873-878
pubmed: 31113986
Tohoku J Exp Med. 2020;251(3):183-191
pubmed: 32669486
PLoS One. 2021 Feb 2;16(2):e0246304
pubmed: 33529192
Sci Transl Med. 2013 Jan 30;5(170):170ra14
pubmed: 23363978
Lancet Diabetes Endocrinol. 2015 Dec;3(12):958-67
pubmed: 26388413
Diabetes Care. 2009 Nov;32(11):2123-32
pubmed: 19875607
Lancet Diabetes Endocrinol. 2014 Jun;2(6):474-80
pubmed: 24731674
Diabetes Res Clin Pract. 2020 Feb;160:108002
pubmed: 31904446
Intern Med. 2020 Jan 15;59(2):175-180
pubmed: 31554753
J Epidemiol. 2016;26(4):224-32
pubmed: 26725285
Diabet Med. 2021 Aug;38(8):e14522
pubmed: 33434318
J Diabetes Res. 2020 Aug 24;2020:1032049
pubmed: 32908932
Int J Mol Sci. 2020 Oct 31;21(21):
pubmed: 33142938
Nutrients. 2017 Apr 14;9(4):
pubmed: 28420094
Ann Hepatol. 2019 Mar - Apr;18(2):298-303
pubmed: 31040092
Diabetes Res Clin Pract. 2015 Mar;107(3):320-31
pubmed: 25638454
Ann Transl Med. 2021 Feb;9(4):326
pubmed: 33708953
Hepatology. 2019 Aug;70(2):711-724
pubmed: 30556145
Nutr Metab (Lond). 2019 Sep 13;16:64
pubmed: 31528183
J Clin Hypertens (Greenwich). 2021 Dec;23(12):2071-2077
pubmed: 34806282
Sci Rep. 2017 Jul 5;7(1):4649
pubmed: 28680048
Obesity (Silver Spring). 2007 Jul;15(7):1841-50
pubmed: 17636103
Diabetes Care. 2008 Oct;31(10):1949-54
pubmed: 18591401
Gastroenterol Hepatol Bed Bench. 2017 Winter;10(Suppl1):S1-S7
pubmed: 29511464
Circ J. 2002 Nov;66(11):987-92
pubmed: 12419927
Arch Intern Med. 2011 Aug 8;171(15):1352-60
pubmed: 21824948
Public Health Nutr. 2015 Nov;18(16):3013-9
pubmed: 25686619
J Diabetes Investig. 2019 May;10(3):837-845
pubmed: 30204299
Metabolism. 2017 Jul;72:94-108
pubmed: 28641788

Auteurs

Akiko Morinaga (A)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Kazuyo Iwanaga (K)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Kaori Maki (K)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Tamami Ueno (T)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Kazumi Kawano (K)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Shunsuke Funakoshi (S)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Toshitaka Yamanokuchi (T)

Department of Physical Therapy, Faculty of Medical Science, Fukuoka International University of Health and Welfare, Fukuoka, Japan.

Masayoshi Tsuji (M)

Department of Lifestyle and Welfare Information, Kindai University Kyushu Junior College, Iizuka, Japan.

Makiko Abe (M)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Atsushi Satoh (A)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Miki Kawazoe (M)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Toshiki Maeda (T)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Chikara Yoshimura (C)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Koji Takahashi (K)

Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Kazuhiro Tada (K)

Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Kenji Ito (K)

Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Tetsuhiko Yasuno (T)

Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Daiji Kawanami (D)

Department of Endocrinology and Diabetes Mellitus, Fukuoka University School of Medicine, Fukuoka, Japan.

Kosuke Masutani (K)

Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Hisatomi Arima (H)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan harima@fukuoka-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH